ExploraMed

ExploraMed is a company dedicated to identifying, creating, and developing new medical devices that address unmet global healthcare needs. It operates an incubator leveraging substantial financial and intellectual resources, offering expertise in clinical, engineering, legal, strategic marketing, and financing to accelerate the development of innovative technologies.

Joshua Makower MD

Founder and Executive Chairman

7 past transactions

Revelle Aesthetics

Seed Round in 2018
Revelle Aesthetics is a medical device company specializing in aesthetic solutions. It was founded by industry experts from ExploraMed, a leading medtech incubator. The company focuses on developing innovative devices to address women's aesthetic concerns, initially targeting cellulite reduction.

Willow

Series A in 2015
Willow Inc., established in 2014 and headquartered in Mountain View, California, specializes in the manufacture of wearable breast pumps for women. The company offers a range of products including milk bags, accessories such as flanges and tubes, and replacement parts. Willow's flagship product is an in-bra wearable breast pump designed to provide mothers with mobility and hands-free convenience during breastfeeding. The company also provides pumping bras, cases, and other breastfeeding essentials.

Nuelle

Series A in 2014
Nuelle is a sexual wellness and intimate care company focused on delivering groundbreaking solutions made specifically for women. It marries its experience in healthcare solutions, consumer products, and technology with a deep understanding of women’s unfulfilled needs. From inception, Nuelle has taken a holistic view of these needs and desires. They worked closely with thought leaders and experts in women’s sexual medicine and wellness including physicians, sex therapists, physical therapists, and psychologists. Together we developed insights that allow Nuelle to translate its scientific approach to understanding.

Vibrynt

Series A in 2007
Vibrynt operates in the medical device sector and offers a system designed to assist with weight loss by limiting food consumption.

Moximed

Seed Round in 2007
Moximed develops and provides the Atlas System, an implantable joint unloader designed to alleviate pain and preserve mobility in patients with medial compartment knee osteoarthritis. Its outpatient treatment option aims to improve quality of life for those not responsive to other therapies or candidates for knee replacement.

NeoTract

Venture Round in 2006
NeoTract, Inc. is a medical device company specializing in the development and manufacture of minimally invasive surgical devices for urological disorders. Founded in 2004 and headquartered in Pleasanton, California, NeoTract focuses on the UroLift system, which is designed to treat men with enlarged prostates while preserving normal sexual function. The company serves a diverse customer base across the United States, Europe, Australia, Canada, Mexico, and South Korea. As a subsidiary of Teleflex Urology Limited, NeoTract aims to address critical needs in the urology field through innovative clinical solutions.

Acclarent

Seed Round in 2004
Acclarent, Inc. is a medical device company focused on developing innovative technologies for ear, nose, and throat (ENT) patients. The company specializes in balloon sinuplasty devices, which are minimally invasive tools designed to assist physicians in treating chronic sinusitis. These devices enable doctors to navigate sinus anatomy effectively, facilitating the opening of blocked sinus ostia and passageways to promote proper sinus drainage. Acclarent's Balloon Sinuplasty technology and associated Relieva product portfolio provide alternatives to traditional endoscopic surgical methods. The company's devices received FDA clearance and were commercially launched in the United States in 2005, marking a significant advancement in the treatment options available for patients with sinus-related conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.